Target Audience
This activity has been designed to meet the educational needs of physicians, pharmacists, and registered nurses/advanced practice providers involved in the care of patients with inflammatory bowel disease.
Educational Objectives
After completing this activity, the participant should be better able to:
Educational Objectives
After completing this activity, the participant should be better able to:
• Differentiate between the mechanisms of action, safety, and efficacy of current FDA-approved therapies for Crohn’s disease and ulcerative colitis.
• Formulate individualized treatment plans for patients of different ages, genders, and understand the special needs of vulnerable populations.
• Describe the novel mechanisms of action in current experimental therapies for IBD in approved clinical trials.
• Identify important health care screenings that pertain to patients with inflammatory bowel disease.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 5.75 contact hour(s) (0.575 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA4008162-9999-21-2892-L01-P
Type of Activity: Application
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 5.75 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs
(i.e., physical, dietary, etc).
Please contact Kelly Fitzgerald at (646)937-2628
*prior to live event
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the Crohn’s & Colitis Foundation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.